157 related articles for article (PubMed ID: 11817595)
41. Early disease course and predictors of disability in juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3 year prospective study.
Selvaag AM; Lien G; Sørskaar D; Vinje O; Førre Ø; Flatø B
J Rheumatol; 2005 Jun; 32(6):1122-30. PubMed ID: 15940778
[TBL] [Abstract][Full Text] [Related]
42. The cost of systemic sclerosis.
Bernatsky S; Hudson M; Panopalis P; Clarke AE; Pope J; Leclercq S; St Pierre Y; Baron M;
Arthritis Rheum; 2009 Jan; 61(1):119-23. PubMed ID: 19116974
[TBL] [Abstract][Full Text] [Related]
43. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.
Boonen A; Brinkhuizen T; Landewé R; van der Heijde D; Severens JL
Ann Rheum Dis; 2010 Jun; 69(6):1123-8. PubMed ID: 20439293
[TBL] [Abstract][Full Text] [Related]
44. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
45. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
46. The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada.
Kobelt G; Andlin-Sobocki P; Maksymowych WP
J Rheumatol; 2006 Apr; 33(4):732-40. PubMed ID: 16583476
[TBL] [Abstract][Full Text] [Related]
47. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
Li X; Gignac MA; Anis AH
Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
[TBL] [Abstract][Full Text] [Related]
48. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
49. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre.
Aggarwal A; Chandran S; Misra R
Natl Med J India; 2006; 19(4):187-91. PubMed ID: 17100104
[TBL] [Abstract][Full Text] [Related]
50. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
51. Health care costs associated with posttraumatic stress disorder symptoms in women.
Walker EA; Katon W; Russo J; Ciechanowski P; Newman E; Wagner AW
Arch Gen Psychiatry; 2003 Apr; 60(4):369-74. PubMed ID: 12695314
[TBL] [Abstract][Full Text] [Related]
52. Cost of multiple sclerosis in the Czech Republic: the COMS study.
Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
[TBL] [Abstract][Full Text] [Related]
53. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
54. Pain and disability, perceptions and beliefs of a rural Indian population: A WHO-ILAR COPCORD study. WHO-International League of Associations for Rheumatology. Community Oriented Program for Control of Rheumatic Diseases.
Chopra A; Saluja M; Patil J; Tandale HS
J Rheumatol; 2002 Mar; 29(3):614-21. PubMed ID: 11908580
[TBL] [Abstract][Full Text] [Related]
55. Cost of care of schizophrenia: a study of Indian out-patient attenders.
Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
[TBL] [Abstract][Full Text] [Related]
56. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
[TBL] [Abstract][Full Text] [Related]
57. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
[TBL] [Abstract][Full Text] [Related]
58. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.
Kang IO; Lee SY; Kim SY; Park CY
Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741
[TBL] [Abstract][Full Text] [Related]
59. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
60. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
